U.S. Beverage Stock News

NYSE:REZI
NYSE:REZIBuilding

Why Resideo Technologies (REZI) Is Down 7.5% After Mixed 2025 Results And Cautious 2026 Outlook – And What's Next

Resideo Technologies reported past fourth-quarter 2025 results with sales of US$1,895 million and net income of US$136 million, alongside full-year 2025 sales of US$7.47 billion but a net loss of US$527 million. The company also issued 2026 guidance calling for net revenue of US$1,866 million to US$1,890 million in the first quarter and US$7.80 billion to US$7.90 billion for the full year, highlighting a contrast between recent quarterly profitability and a loss-making full year. Against...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Is Up 5.7% After Authorizing US$500M Buyback Program Has The Bull Case Changed?

RB Global, Inc. recently announced that its Board of Directors has authorized a share repurchase program of up to US$500,000,000, subject to Toronto Stock Exchange approval and funded through cash reserves or its senior credit facility. This sizable buyback authorization, coming alongside strong quarterly results that exceeded analyst expectations, highlights management’s confidence in deploying capital to support shareholder value. We’ll now examine how the newly authorized US$500,000,000...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Assessing Cathay General Bancorp (CATY) Valuation After Recent Share Price Weakness

Cathay General Bancorp (CATY) has drawn investor attention after a recent share price decline, including a 12% drop over the past month, even as the bank reports US$745.261m in revenue and US$315.124m in net income. See our latest analysis for Cathay General Bancorp. That recent 12% monthly share price pullback fits into a softer short term trend, with a 30 day share price return of an 11.79% decline and a 90 day return of a 3.15% decline, even though the 1 year total shareholder return of...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Is Neogen (NEOG) Pricing Make Sense After Mixed Share Performance This Year

If you are trying to figure out whether Neogen's current share price makes sense, you are not alone. A closer look at its valuation tools can help you frame that question more clearly. Neogen recently closed at US$9.70, with returns of a 13% decline over 7 days, a 10.2% decline over 30 days, a 38.6% gain year to date, and a 2.8% decline over the last year. This combination gives a mixed picture of how the market is currently pricing the stock. Recent coverage around Neogen has focused on the...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

Why Preformed Line Products' (PLPC) Rising Sales With Softer EPS May Recast Its Margin Narrative

Preformed Line Products Company previously reported fourth-quarter 2025 results, with sales rising to US$173.11 million while net income eased to US$8.44 million, and full-year 2025 sales increasing to US$669.34 million alongside slightly lower earnings per share. The combination of higher revenue with reduced profitability suggests rising costs or margin pressure, raising questions about the quality and sustainability of recent growth. We’ll now examine how rising full-year sales alongside...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

How Investors May Respond To Allot (ALLT) Returning To Profitability With 2026 Revenue Growth Guidance

In February 2026, Allot Ltd. reported fourth-quarter 2025 sales of US$28.39 million and net income of US$2.9 million, alongside full-year 2025 sales of US$101.99 million and net income of US$3.71 million, marking a shift from a loss a year earlier. At the same time, the company guided for 2026 revenue of US$113 million to US$117 million, signaling management’s confidence in accelerating growth after its return to profitability. Next, we’ll examine how Allot’s return to profitability and...
NasdaqGS:LLYV.K
NasdaqGS:LLYV.KConsumer Services

Is Liberty Live (LLYV.K) Rotating Legal Leadership to Quietly Reposition Its Deal‑Making Strategy?

Liberty Media Corporation recently announced that Renee Wilm will move from her role as Chief Legal Officer and Chief Administrative Officer of Liberty Media, Liberty Live and Liberty Broadband to become Senior Advisor later in 2026, while continuing as Chief Legal Officer at GCI Liberty, Inc. This shift marks a change in legal and transactional leadership after more than two decades of Ms. Wilm’s involvement in major deals and restructurings across the Liberty group. Next, we’ll assess how...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Kyivstar Group (NasdaqGS:KYIV) Valuation Check As Recent Weak Trading Contrasts With DCF Upside Estimate

Why Kyivstar Group is on investors’ radar today Kyivstar Group (KYIV) has caught investor attention after recent trading left the shares around $11.77, with performance over the past month and past 3 months both in negative territory. See our latest analysis for Kyivstar Group. Recent trading has been weak, with a 1-day share price return showing a 0.93% decline and a 90-day share price return showing a 17.58% decline. However, the 1-year total shareholder return of 1.99% indicates that...
NasdaqGS:INSG
NasdaqGS:INSGCommunications

Is Inseego's (INSG) Unified 5G Edge Strategy Deepening Its Moat or Stretching It Too Thin?

Inseego recently introduced the MiFi PRO M4 enterprise mobile router, built on its new ConnectOS software and Qualcomm’s Dragonwing MBB Gen 3 platform, while also unveiling an enhanced Inseego Subscribe SaaS BSS solution for complex enterprise and government subscriber lifecycle management. Together, these launches highlight Inseego’s push to create a unified wireless edge architecture that blends 5G hardware, cloud management, and enterprise-grade security into an integrated offering for...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT)

LeMaitre Vascular, Inc. recently reported fourth-quarter 2025 sales of US$64.45 million and net income of US$15.58 million, alongside full-year 2025 sales of US$249.6 million and net income of US$57.73 million, and announced a higher quarterly dividend of US$0.25 per share plus a share repurchase program of up to US$100 million through February 18, 2027. In addition, the company issued 2026 guidance that points to higher sales and earnings and plans to highlight its outlook at the Leerink...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Assessing Yalla Group (YALA) Valuation After New US$150 Million Buyback And Q1 2026 Revenue Guidance

Why Yalla Group (YALA) is back on investors’ radar Yalla Group (YALA) has drawn fresh attention after its board approved a new share repurchase program of up to US$150 million, alongside first quarter 2026 revenue guidance that factors in the timing of Ramadan. See our latest analysis for Yalla Group. Those moves come after a period where the 1 year total shareholder return of 76.9% contrasts with a more muted 0.7% year to date share price return at US$7.11, suggesting recent momentum has...
NYSE:MTD
NYSE:MTDLife Sciences

Why Mettler-Toledo (MTD) Is Down 5.8% After Tariff-Driven Margin Squeeze And Cautious 2025 Outlook

In Q2 2025, Mettler-Toledo International reported marginal revenue growth but weaker gross and operating margins as higher tariffs and macroeconomic pressures weighed on profitability, and management issued cautious full-year 2025 guidance. Even as near-term earnings face pressure, the company is emphasizing bioprocessing and manufacturing onshoring as areas it believes could reshape its longer-term business mix. We’ll now examine how the tariff-driven margin squeeze highlighted in the...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Exact Sciences EHR Outreach Lifts CRC Screening And Fuels Investor Interest

Exact Sciences, Amalgam Rx and Privia Health report materially higher colorectal cancer screening rates using EHR-enabled outreach and at home noninvasive tests. The coordinated program is described as scalable and has surpassed national screening benchmarks during Colorectal Cancer Awareness Month. The initiative focuses on closing screening gaps by embedding screening prompts and workflows directly into clinical systems and patient communications. For investors watching NasdaqCM:EXAS,...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

A Look At Nurix Therapeutics (NRIX) Valuation After Expanded Equity Distribution Agreement

Why Nurix Therapeutics (NRIX) moved after its latest capital move Nurix Therapeutics (NRIX) recently expanded its equity distribution agreement, giving it room to sell up to $413.65 million of common stock through Piper Sandler. This step directly affects its capital-raising flexibility and potential dilution. See our latest analysis for Nurix Therapeutics. The capital plan arrives after a tougher few months for the share price, with a 30 day share price return showing an 8% decline and a 90...
NYSE:VTOL
NYSE:VTOLEnergy Services

Will Solid Q4 Results, Dividend, And 2026 Guidance Change Bristow Group's (VTOL) Narrative

On February 25, 2026, Bristow Group Inc. reported fourth-quarter 2025 sales of US$377.26 million and net income of US$18.42 million, alongside a US$0.125 quarterly dividend and affirmed 2026 revenue guidance of US$1.58 billion to US$1.69 billion. The combination of stronger full-year 2025 profitability, reiterated revenue expectations for 2026, and continued cash returns via dividends underscores management’s confidence in Bristow’s operating outlook. With 2026 revenue guidance now on the...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Assessing Plexus (PLXS) Valuation After A Strong 1 Year Share Price Rally

Recent share performance and what it means for Plexus (PLXS) investors Plexus (PLXS) has caught investor attention after a strong past 3 months, with a total return above 20% and a 1 year return above 50%, despite a weaker month. That mix of shorter term softness and stronger longer term gains raises a practical question for you as an investor: whether the current share price around $191.58 still lines up with the company’s fundamentals. See our latest analysis for Plexus. Recent trading has...
NYSE:ACCO
NYSE:ACCOCommercial Services

ACCO Brands (ACCO) Return To Profit Tests Bearish Earnings Narrative

ACCO Brands (ACCO) has reported its FY 2025 third quarter with revenue of US$383.7 million and EPS of US$0.04, alongside net income of US$4 million. The trailing 12 month figures show revenue of US$1.54 billion and EPS of US$0.44 supported by net income of US$40.6 million. Over recent quarters the company has seen revenue move from US$438.3 million with EPS of a US$1.29 loss and a net loss of US$125.2 million in Q2 2024 to US$394.8 million with EPS of US$0.32 and net income of US$29.2 million...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Assessing Nuvalent (NUVL) Valuation After Wider Losses And A New Shelf Registration

Why Nuvalent’s latest results are in focus Nuvalent (NUVL) is back on investors’ radar after reporting a fourth quarter net loss of US$118.71 million and a full-year net loss of US$425.38 million, along with a new US$458.37 million shelf registration filing. See our latest analysis for Nuvalent. At a share price of US$102.32, Nuvalent has seen a 1-day share price return of 2.93% and a year-to-date share price return of 1.47%. Its 1-year total shareholder return of 51.86% and very large 3-year...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Is Starbucks (SBUX) Pricing Look Stretched After Recent Share Price Rebound?

Wondering if Starbucks at around US$99.77 is offering you real value today, or if the easy money has already been made? You are not alone in asking whether the current price lines up with what the business is actually worth. The stock has returned 3.1% over the last 7 days, 0.3% over the last 30 days and 18.8% year to date, with a 1.4% return over 1 year, 8.4% over 3 years and 2.8% over 5 years, which gives investors a mixed set of signals about recent momentum and changing risk...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble’s Paris Grand Role And Insider Selling Shape Valuation Picture

Trimble is supplying technology for the Paris Grand construction project, keeping the company tied to one of Europe’s highest profile infrastructure builds. At the same time, company insiders have been consistently selling shares of NasdaqGS:TRMB over the past year, with no insider purchases reported. These two threads, project execution in France and insider activity at home, give investors fresh information on Trimble beyond recent earnings headlines. Trimble, trading at $70.45, sits at...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Revenue Record And SiCore Wins Tested Against Rich Valuation

Amprius Technologies (NYSE:AMPX) reported record fourth quarter revenue. The company highlighted broad adoption of its second generation SiCore silicon anode batteries. Nokia Drone Networks selected Amprius SiCore batteries, adding a high profile commercial reference. Amprius said it is ahead of schedule on NDAA compliance, improving eligibility for future U.S. government contracts. Amprius focuses on high performance silicon anode batteries aimed at applications where weight, power, and...
NYSE:PNFP
NYSE:PNFPBanks

Is Pinnacle Financial Partners (PNFP) Pricing Reflect Recent Regional Bank Concerns Accurately?

If you are wondering whether Pinnacle Financial Partners is offering fair value at its current share price, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$87.29, with returns of a 5.8% decline over 7 days, a 14.6% decline over 30 days, an 8.2% decline year to date, an 11.1% decline over 1 year, 58.6% over 3 years, and 1.1% over 5 years, which gives a mixed picture of recent and longer term performance. Recent news around...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox Creator Push And AI Safety Tools Meet Depressed Share Price

Roblox has launched two new creator programs, Roblox Incubator and Roblox Jumpstart, aimed at helping developers build higher quality games for a more mature audience. The company has also rolled out AI-powered chat moderation that can automatically rephrase inappropriate messages in real time to help keep conversations safer and more civil. Roblox, listed as NYSE:RBLX, is introducing these creator programs and AI tools at a time when its share price is $62.65. The stock has seen a 16.5%...
NYSE:HRTG
NYSE:HRTGInsurance

Heritage Insurance (HRTG) Combined Ratio Breakthrough Reinforces Bullish Profitability Narrative

Heritage Insurance Holdings (HRTG) just posted its FY 2025 third quarter results, reporting revenue of US$212.5 million and basic EPS of US$1.63, alongside a combined ratio of 72.9%. This puts underwriting performance in clear focus. The company’s quarterly revenue has moved in a tight band, from US$210.3 million in Q4 2024 to US$212.5 million in Q3 2025, while basic EPS increased from US$0.66 to US$1.63 over the same period. This sets the scene for investors to examine how margins and...